• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较预测社区获得性肺炎患者 30 天死亡率的风险评分表现。

Comparison of performances between risk scores for predicting mortality at 30 days in patients with community acquired pneumonia.

机构信息

School of Medicine, Universidad de La Sabana. Km 7, Autonorte de Bogota, Chía, Cundinamarca, 250001, Colombia.

Master's Student in Epidemiology, Universidad de La Sabana, Chía, Colombia.

出版信息

BMC Infect Dis. 2024 Sep 3;24(1):912. doi: 10.1186/s12879-024-09792-1.

DOI:10.1186/s12879-024-09792-1
PMID:39227756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11370103/
Abstract

BACKGROUND

Risk scores facilitate the assessment of mortality risk in patients with community-acquired pneumonia (CAP). Despite their utilities, there is a scarcity of evidence comparing the various RS simultaneously. This study aims to evaluate and compare multiple risk scores reported in the literature for predicting 30-day mortality in adult patients with CAP.

METHODS

A retrospective cohort study on patients diagnosed with CAP was conducted across two hospitals in Colombia. The areas under receiver operating characteristic curves (ROC-curves) were calculated for the outcome of survival or death at 30 days using the scores obtained for each of the analyzed questionnaires.

RESULTS

A total of 7454 potentially eligible patients were included, with 4350 in the final analysis, of whom 15.2% (662/4350) died within 30 days. The average age was 65.4 years (SD: 21.31), and 59.5% (2563/4350) were male. Chronic kidney disease was 3.7% (9.2% vs. 5.5%; p < 0.001) (OR: 1.85) higher in subjects who died compared to those who survived. Among the patients who died, 33.2% (220/662) presented septic shock compared to 7.3% (271/3688) of the patients who survived (p < 0.001). The best performances at 30 days were shown by the following scores: PSI, SMART-COP and CURB 65 scores with the areas under ROC-curves of 0.83 (95% CI: 0.8-0.85), 0.75 (95% CI: 0.66-0.83), and 0.73 (95% CI: 0.71-0.76), respectively. The RS with the lowest performance was SIRS with the area under ROC-curve of 0.53 (95% CI: 0.51-0.56).

CONCLUSION

The PSI, SMART-COP and CURB 65, demonstrated the best diagnostic performances for predicting 30-day mortality in patients diagnosed with CAP. The burden of comorbidities and complications associated with CAP was higher in patients who died.

摘要

背景

风险评分有助于评估社区获得性肺炎(CAP)患者的死亡风险。尽管它们具有实用性,但同时比较各种 RS 的证据很少。本研究旨在评估和比较文献中报告的多种风险评分,以预测成人 CAP 患者的 30 天死亡率。

方法

在哥伦比亚的两家医院进行了一项诊断为 CAP 的患者回顾性队列研究。使用为每个分析问卷获得的评分,计算出生存或 30 天内死亡的结果的接受者操作特征曲线(ROC 曲线)下面积。

结果

共有 7454 名潜在合格患者入选,最终分析了 4350 名患者,其中 15.2%(662/4350)在 30 天内死亡。平均年龄为 65.4 岁(标准差:21.31),59.5%(2563/4350)为男性。与存活者相比,死亡者的慢性肾脏病发病率高 3.7%(9.2%比 5.5%;p<0.001)(OR:1.85)。在死亡患者中,33.2%(220/662)出现感染性休克,而存活患者中只有 7.3%(271/3688)(p<0.001)。在 30 天内表现最佳的评分如下:PSI、SMART-COP 和 CURB 65 评分,ROC 曲线下面积分别为 0.83(95%CI:0.8-0.85)、0.75(95%CI:0.66-0.83)和 0.73(95%CI:0.71-0.76)。表现最差的 RS 是 SIRS,ROC 曲线下面积为 0.53(95%CI:0.51-0.56)。

结论

PSI、SMART-COP 和 CURB 65 对预测 CAP 患者 30 天死亡率的诊断性能最佳。死亡患者的合并症和并发症负担更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b425/11370103/0d61589c1ec0/12879_2024_9792_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b425/11370103/0d61589c1ec0/12879_2024_9792_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b425/11370103/0d61589c1ec0/12879_2024_9792_Fig1_HTML.jpg

相似文献

1
Comparison of performances between risk scores for predicting mortality at 30 days in patients with community acquired pneumonia.比较预测社区获得性肺炎患者 30 天死亡率的风险评分表现。
BMC Infect Dis. 2024 Sep 3;24(1):912. doi: 10.1186/s12879-024-09792-1.
2
Performance of risk scores in predicting mortality at 3, 6, and 12 months in patients diagnosed with community-acquired pneumonia.风险评分在预测社区获得性肺炎患者 3、6 和 12 个月死亡率中的表现。
BMC Pulm Med. 2024 Jul 10;24(1):334. doi: 10.1186/s12890-024-03121-7.
3
Short-term mortality of adult inpatients with community-acquired pneumonia: external validation of a modified CURB-65 score.社区获得性肺炎成年住院患者的短期死亡率:改良CURB-65评分的外部验证
Postgrad Med J. 2015 Feb;91(1072):77-82. doi: 10.1136/postgradmedj-2014-132802. Epub 2015 Jan 24.
4
Efficacy of the quick sequential organ failure assessment for predicting clinical outcomes among community-acquired pneumonia patients presenting in the emergency department.快速序贯器官衰竭评估在预测急诊科就诊的社区获得性肺炎患者临床结局中的疗效。
BMC Infect Dis. 2020 Apr 29;20(1):316. doi: 10.1186/s12879-020-05044-0.
5
Expanded A-DROP Score: A New Scoring System for the Prediction of Mortality in Hospitalized Patients with Community-acquired Pneumonia.扩展 A-DROP 评分:一种用于预测社区获得性肺炎住院患者死亡率的新评分系统。
Sci Rep. 2018 Oct 1;8(1):14588. doi: 10.1038/s41598-018-32750-2.
6
Elevated Red Blood Cell Distribution Width Combined White Blood Cell in Peripheral Blood Routine Have a Better Sensitivity than CURB-65 Scores in Predicting ICU Admission and Mortality in Adult Community-Acquired Pneumonia Patients.外周血血常规中红细胞分布宽度升高联合白细胞在预测成人社区获得性肺炎患者入住重症监护病房及死亡率方面比CURB-65评分具有更高的敏感性。
Clin Lab. 2019 Mar 1;65(3). doi: 10.7754/Clin.Lab.2018.180828.
7
CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS.CURB-65、PSI 和 APACHE II 评估 PROWESS 中严重脓毒症和社区获得性肺炎患者的死亡风险。
J Intensive Care Med. 2011 Jan-Feb;26(1):34-40. doi: 10.1177/0885066610383949.
8
Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.住院社区获得性肺炎的预后因素:一项前瞻性观察队列的回顾性研究
BMC Pulm Med. 2017 May 2;17(1):78. doi: 10.1186/s12890-017-0424-4.
9
External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia.CURSI 标准(意识模糊、尿素、呼吸频率和休克指数)在成人社区获得性肺炎住院患者中的外部验证。
BMC Infect Dis. 2014 Jan 22;14:39. doi: 10.1186/1471-2334-14-39.
10
Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study.COVID-19 住院患者社区获得性肺炎严重程度评估工具:验证和临床适用性研究。
Clin Microbiol Infect. 2021 Jul;27(7):1037.e1-1037.e8. doi: 10.1016/j.cmi.2021.03.002. Epub 2021 Apr 2.

引用本文的文献

1
Association between oxygen debt (DEOx) variability over time and clinical outcomes in critically ill COVID-19 patients: an observational study.危重症COVID-19患者氧债(DEOx)随时间的变异性与临床结局之间的关联:一项观察性研究。
BMC Pulm Med. 2025 Aug 7;25(1):379. doi: 10.1186/s12890-025-03858-9.
2
The clinical usefulness of neutrophil percentage/albumin ratio in predicting the one-month mortality in chronic obstructive pulmonary disease patients hospitalized with community-acquired pneumonia.中性粒细胞百分比/白蛋白比值在预测因社区获得性肺炎住院的慢性阻塞性肺疾病患者1个月死亡率中的临床应用价值。
BMC Pulm Med. 2025 Jun 9;25(1):288. doi: 10.1186/s12890-025-03757-z.
3

本文引用的文献

1
The Battle of the Pneumonia Predictors: A Comprehensive Meta-Analysis Comparing the Pneumonia Severity Index (PSI) and the CURB-65 Score in Predicting Mortality and the Need for ICU Support.肺炎预测指标之战:一项综合荟萃分析,比较肺炎严重程度指数(PSI)和CURB - 65评分在预测死亡率及重症监护病房(ICU)支持需求方面的情况
Cureus. 2023 Jul 29;15(7):e42672. doi: 10.7759/cureus.42672. eCollection 2023 Jul.
2
Community-Acquired Pneumonia.社区获得性肺炎
N Engl J Med. 2023 Aug 17;389(7):632-641. doi: 10.1056/NEJMcp2303286.
3
Outcomes of community-acquired pneumonia using the Pneumonia Severity Index the CURB-65 in routine practice of emergency departments.
Multiplex PCR Pneumonia Panel in Critically Ill Patients Did Not Modify Mortality: A Cohort Study.
重症患者多重PCR肺炎检测组未改变死亡率:一项队列研究。
Antibiotics (Basel). 2025 Feb 28;14(3):245. doi: 10.3390/antibiotics14030245.
4
Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients.Pentraxin-3作为非中性粒细胞减少的侵袭性肺曲霉病患者的一种新型预后生物标志物。
Microbiol Spectr. 2025 Mar 4;13(3):e0294524. doi: 10.1128/spectrum.02945-24. Epub 2025 Jan 29.
在急诊科常规诊疗中运用肺炎严重程度指数(PSI)及CURB-65评估社区获得性肺炎的转归。
ERJ Open Res. 2023 May 2;9(3). doi: 10.1183/23120541.00051-2023. eCollection 2023 Jul.
4
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia.ERS/ESICM/ESCMID/ALAT 指南:严重社区获得性肺炎管理。
Intensive Care Med. 2023 Jun;49(6):615-632. doi: 10.1007/s00134-023-07033-8. Epub 2023 Apr 4.
5
Acid-base imbalance as a risk factor for mortality among COVID-19 hospitalized patients.酸碱失衡是 COVID-19 住院患者死亡的一个风险因素。
Biosci Rep. 2023 Mar 29;43(3). doi: 10.1042/BSR20222362.
6
The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures.成人社区获得性肺炎的微生物病因学:从经典细菌学到宿主转录特征。
Clin Microbiol Rev. 2022 Dec 21;35(4):e0001522. doi: 10.1128/cmr.00015-22. Epub 2022 Sep 27.
7
Validity of the ROX index in predicting invasive mechanical ventilation requirement in pneumonia.ROX 指数预测肺炎患者有创机械通气需求的有效性。
BMJ Open Respir Res. 2022 Sep;9(1). doi: 10.1136/bmjresp-2022-001320.
8
Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia: A Systematic Review, Meta-analysis, and Meta-regression of Randomized Control Trials.糖皮质激素对社区获得性肺炎病死率和临床治愈率的影响:一项随机对照试验的系统评价、荟萃分析和荟萃回归。
Chest. 2023 Mar;163(3):484-497. doi: 10.1016/j.chest.2022.08.2229. Epub 2022 Sep 7.
9
Comparison of the prognostic performance of the CURB-65 and a modified version of the pneumonia severity index designed to identify high-risk patients using the International Community-Acquired Pneumonia Collaboration Cohort.CURB-65 与改良版肺炎严重指数在识别国际社区获得性肺炎协作队列高危患者中的预后性能比较。
Respir Med. 2022 Aug-Sep;200:106884. doi: 10.1016/j.rmed.2022.106884. Epub 2022 Jun 13.
10
CURB-65, qSOFA, and SIRS Criteria in Predicting In-Hospital Mortality of Critically Ill COVID-19 Patients; a Prognostic Accuracy Study.CURB-65、qSOFA和全身炎症反应综合征(SIRS)标准预测危重症COVID-19患者院内死亡率的预后准确性研究
Arch Acad Emerg Med. 2022 May 10;10(1):e36. doi: 10.22037/aaem.v10i1.1565. eCollection 2022.